CAMP4 TherapeuticsListed
camp4tx.combiotech_life_sciences
CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP Pla…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP Pla…
Details are not available yet. The company remains listed.
Ensoma is an in vivo hematopoietic stem cell (HSC) engineering company focused on creating a new kind of genomic medicine that treats diseases with a one-time treatment regimen by…
NodThera is a biotech company focused on developing therapies that target the NLRP3 inflammasome to treat chronic inflammatory diseases at their source.
Nouscom is a next-generation immunotherapy company developing engineered viral vectored vaccines for treatment of cancer, utilizing proprietary platforms to induce strong immune r…
Karius is a company focused on architecture, offering various architectural services and projects.
TMRW® Life is a platform connecting hotel operations and guests, enhancing hotel management through mobile applications.
Rallybio is a clinical-stage biotech company committed to delivering groundbreaking therapies with the potential to truly transform the lives of millions of patients with devastat…
Surrozen is pioneering therapies that harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. The company develops multi-target antibody therapeutics…
Details are not available yet. The company remains listed.
Homology Medicines, Inc. is a biotechnology company focused on developing genetic medicines to treat and cure rare genetic diseases through gene editing and gene therapy.
Crinetics is a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors.
Aprea Therapeutics is a clinical-stage biopharmaceutical company focused on developing DDR-targeted therapies for cancer treatment, aiming to exploit specific vulnerabilities in c…
IDEAYA is a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapeutics for cancer, particularly through synthetic lethali…
A clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases.
RareCyte is a Precision Biology company specializing in spatial biology and liquid biopsy solutions, providing advanced platforms and expert services for high-resolution insights…
Impel NeuroPharma is a late-stage pharmaceutical company focused on utilizing proprietary technology to develop and commercialize transformative therapies for patients suffering f…
Expansion Therapeutics is a biotech firm focused on developing treatments for RNA-mediated diseases, securing $80 million in Series B funding in 2021. The company aims to create o…
GlycoEra is focused on developing biologics to selectively target and degrade specific circulating proteins, particularly autoantibodies, that drive autoimmune diseases. Their inn…
Details are not available yet. The company remains listed.
Mendra is a biopharmaceutical company focused on improving the development and commercialization of rare disease therapies worldwide, utilizing AI to address challenges in patient…
Precede Biosciences is a precision diagnostics and data company redefining what can be learned from a simple blood draw. By unlocking genome-wide transcriptional biology through a…
Kinaset Therapeutics is focused on developing inhaled therapeutics to address significant unmet medical needs in respiratory diseases. Their lead clinical candidate, frevecitinib…
Details are not available yet. The company remains listed.
Lifordi is among the first companies to leverage the success of antibody-drug conjugates (ADC) in oncology to develop treatments for autoimmune and inflammatory disorders. They fo…
Prolynx is a biotechnology company dedicated to developing ultra-long-acting medicines for obesity and other metabolic diseases. The Company is advancing a proprietary portfolio o…